{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-004565","form_type":"8-K","ticker":null,"cik":"0001848861","company_name":"Healthcare AI Acquisition Corp.","filed_at":"2023-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.208785+00:00","generated_at":"2026-06-14T01:33:29.169458+00:00","sec_items":["1.01","5.02","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Healthcare AI Acquisition Corp. sees ~92% public shares redeemed; new sponsor and board after special meeting","bullets":["19,824,274 shares tendered for redemption (~$208.99M, $10.54/share); trust account reduced to ~$18.3M with 1.74M Class A shares outstanding.","Shareholders approved extension to June 14, 2024 via $50K/month deposits, removed net tangible asset redemption limit, and allowed founder share conversion.","Sponsor sold 3,184,830 Founder Shares to Atticus Ale, LLC; all existing officers/directors resigned, new board appointed with Zikang Wu as CEO.","Underwriters waived deferred discount; sponsor will exchange 11.1M placement warrants for 500K Class A shares upon business combination."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-004565","json":"https://secwatch.observer/filing/0001477932-23-004565.json","markdown":"https://secwatch.observer/filing/0001477932-23-004565.md","text":"https://secwatch.observer/filing/0001477932-23-004565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/haia_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T01:33:29.169458+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"31aadabf02","claim":"Zikang Wu was appointed as Non-independent Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, the holders of the Founder Shares appointed Zikang Wu as a non-independent director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Non-independent Director"}],"fact_type":"executive_change"},{"claim_id":"3707bcd0d7","claim":"Elizabeth Weymouth resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"419448b0d0","claim":"Xavier Flinois resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"506e7e0e39","claim":"Weiyi Zheng was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, Zikang Wu as the sole director of the Company appointed Weiyi Zheng, Hao Tian, Yuerong Tang and Zixun Jin as directors to join the Board of Directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5506010ed9","claim":"Zixun Jin was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, Zikang Wu as the sole director of the Company appointed Weiyi Zheng, Hao Tian, Yuerong Tang and Zixun Jin as directors to join the Board of Directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"58c33baab8","claim":"Greg Caswill resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"707985c5e6","claim":"Zikang Wu was appointed as Chief Executive Officer at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, Zikang Wu as the sole director of the Company, appointed Zikang Wu as Chief Executive Officer, effective June 12, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"882501240e","claim":"Simon Cottle resigned as Director and Chief Executive Officer at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"965b611ad7","claim":"Yuerong Tang was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, Zikang Wu as the sole director of the Company appointed Weiyi Zheng, Hao Tian, Yuerong Tang and Zixun Jin as directors to join the Board of Directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"99dbe910d7","claim":"James Brooks resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a695196f26","claim":"Patrick Hargutt resigned as Director and Chief Financial Officer at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d025d04c29","claim":"Hao Tian was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, Zikang Wu as the sole director of the Company appointed Weiyi Zheng, Hao Tian, Yuerong Tang and Zixun Jin as directors to join the Board of Directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f88dcefd63","claim":"Robert Piconi resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a01e06a07401666eb73c82f32d961581e7a738ab","claim":"Healthcare AI Acquisition Corp.: Approved amendments to extend business combination deadline to June 14, 2024, remove redemption limitation, and allow founder share conversion on a one-for-one basis (effective 2023-06-09).","evidence_excerpt":"As approved by its shareholders at the Special Meeting held on June 9, 2023, the following proposals were approved: (a) as a special resolution, giving the Company the right to extend the date by which it has to complete a business combination to June 14, 2024 by depositing into the Company’s trust account held by the Trustee (the “ Trust Account ”), the amount of $50,000 for each one-month extension (the “ Extension Amendment Proposal ”); (b) as a special resolution, an amendment to the Articles of Association to remove from the Articles of Association the limitation that the Company may not redeem Public Shares (as defined below) to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Securities Exchange Act of 1934, as amended), of less than $5,000,001 (the “ Redemption Limitation ”) in order to allow the Company to redeem Public Shares irrespective of whether such redemption would exceed th","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-06-09"}],"fact_type":"governance_change"},{"claim_id":"c6e594694a62d65aabc514e0d2c5b43f529eea24","claim":"Healthcare AI Acquisition Corp.: Approved an amendment to the Letter Agreement to allow sponsor to transfer holdings prior to expiration of lock-up (effective 2023-06-09).","evidence_excerpt":"In addition, a proposal was approved as an ordinary resolution, an amendment to the Letter Agreement, to allow the Sponsor to transfer its holdings in the Company prior to the expiration of the applicable lock-up (the “ Letter Agreement Amendment Proposal ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.7,"family_label":"Governance Changes","details":[{"label":"Effective","value":"2023-06-09"}],"fact_type":"governance_change"},{"claim_id":"016457a7604c4dba49d5ec16be7c7dd35df3ab16","claim":"Healthcare AI Acquisition Corp. shareholders approved Founder Share Amendment Proposal - allow Class B conversion to Class A at any time at the 2023-06-09 meeting.","evidence_excerpt":"The Founer Share Amendment Proposal received the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 17,994,347 1,713,963 0 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"32608db80f97c1cec8637ecd343b48648ec27324","claim":"Healthcare AI Acquisition Corp. shareholders approved Redemption Limitation Amendment Proposal - remove net tangible asset redemption limitation at the 2023-06-09 meeting.","evidence_excerpt":"Redemption Limitation Amendment Proposal received the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 17,994,347 1,713,963 0 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"3e7f3cfb8c603d6a8938a5d28714e597d7d5a97a","claim":"Healthcare AI Acquisition Corp. shareholders approved Letter Agreement Amendment Proposal - allow transfer of Class B shares before lock-up expiration at the 2023-06-09 meeting.","evidence_excerpt":"The Letter Agreement Amendment Proposal received the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 17,994,347 1,713,963 0 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"b089ae7b578b01e057be7a2d6671f2ac5e768265","claim":"Healthcare AI Acquisition Corp. shareholders approved Extension Amendment Proposal - amend Articles to extend business combination deadline at the 2023-06-09 meeting.","evidence_excerpt":"Extension Amendment Proposal received the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 17,994,347 1,713,963 0 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223004565/0001477932-23-004565-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"merger approval"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-09"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}